$1.56
-0.14-8.24%
Last update: Nov 10, 5:58 PM
Seres Therapeutics Inc
MCRBNASDAQ
The average analyst price target for Seres Therapeutics is $13.75, 787.1% above the current price. Of 5 analysts, 2 rate it Buy, 1 Hold and 2 Sell. Targets range from $6 to $22. The latest change came on Jun 23, 2026, when HC Wainwright & Co. initiated coverage of Seres Therapeutics with a Buy rating and a $12 price target.
Price Target Range — 9 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
